Management options in decompensated cirrhosis

Neeral L Shah1, Yasmin Pourkazemi Banaei2, Kristen L Hojnowski2

  • 1Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA.

Insights

This review details managing chronic liver disease complications, including portal hypertension, hepatic encephalopathy, hepatorenal syndrome, and bleeding issues in cirrhosis patients. Effective management is crucial for improving patient outcomes and reducing mortality.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Gastroenterology

Background:

  • Chronic liver injury leads to irreversible scarring (cirrhosis), a significant cause of U.S. mortality.
  • Effective patient management in inpatient and outpatient settings is critical for improving morbidity and mortality rates.
  • Cirrhosis affects numerous patients, necessitating comprehensive care strategies.

Purpose of the Study:

  • To provide an overview of key management areas for patients with cirrhosis.
  • To address outpatient care, including portal hypertension, decompensation, and health maintenance.
  • To review common complications such as hepatic encephalopathy, hepatorenal syndrome, and coagulation disorders.

Main Methods:

  • Literature review focusing on current management strategies for cirrhosis complications.
  • Discussion of pathophysiology, acute treatment, and long-term prevention for hepatic encephalopathy.
  • Analysis of hepatorenal syndrome, coagulation assessment, and bleeding/thrombosis management.

Main Results:

  • Outlines recommendations for outpatient health maintenance and screening in cirrhosis patients.
  • Summarizes pathophysiology and treatment for acute hepatic encephalopathy and strategies for prevention.
  • Details hospital-based management of hepatorenal syndrome and assessment of coagulation profiles.

Conclusions:

  • Comprehensive management of cirrhosis complications is essential for patient survival and quality of life.
  • Addressing portal hypertension, hepatic encephalopathy, hepatorenal syndrome, and coagulation issues improves patient care.
  • This review provides a foundation for managing common, critical complications in cirrhosis patients.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
786
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
557
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
664
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
588